OpenAlex
PricingAboutJobs
Log inGet started
Work

Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)

HTML

Year: 1999
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood.v93.3.787
Authors: Ranjana Advani, Hussain I. Saba, Martin S. Tallman, Jacob M. Rowe, Peter H. Wiernik, Joseph Ramek, Kathleen Dugan, Bert Lum, Jenny Villena, Eric Davis, Elisabeth Paietta, Manuel Litchman, Branimir I. Sikic, Peter L. Greenberg
Institutions: Northwestern University, University of Rochester Medicine, Moffitt Cancer Center, Stanford Medicine, University of Rochester
Language: English

Topic: Drug Transport and Resistance Mechanisms
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: acute myeloid leukemia, refractory leukemia, relapsed leukemia, PSC833, valspodar, multidrug resistance, P-glycoprotein, mitoxantrone, etoposide, cytarabine, pharmacokinetic interactions, rhodamine 123 efflux, complete remission, bone marrow hypoplasia
SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, National Center for Research Resources
Awards: G2589705855, General Clinical Research Center, Eastern Cooperative Oncology Group Operations Office, MODULATION OF MULTIDRUG RESISTANCE MECHANISMS
OpenAlex ID: W1249439018
FWCI: 11.11
Cites: 73
Cited by: 166
Related to: 7
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms